Raltegravir: a new antiretroviral class for salvage therapy.
Cahn
Pedro
P
Department of Clinical Research, Fundación Huesped, Buenos Aires, Argentina (C1202ABB). Electronic address: pcahn@huesped.org.ar.
Sued
Omar
O
Department of Clinical Research, Fundación Huesped, Buenos Aires, Argentina (C1202ABB).
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D018432:Drug Resistance, Multiple; D019428:HIV Integrase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D015497:HIV-1; D006801:Humans; D009930:Organic Chemicals / Q000494:pharmacology / Q000627:therapeutic use*; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D016032:Randomized Controlled Trials as Topic; D016879:Salvage Therapy / Q000379:methods*
D019428:HIV Integrase Inhibitors; D009930:Organic Chemicals; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium